DAVID enrichment results showed that in the NSCLC, Lactucin downregulates MEK-ERK pathway, resulting in the downregulation of CyclinD1, CDKs, and upregulation of the p53. This evidence concerns the gene CCND1 and non-small cell lung carcinoma.